tiprankstipranks
Trending News
More News >
FibroGen (DE:1FG)
:1FG
Germany Market

FibroGen (1FG) Technical Analysis

Compare
2 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
FibroGen’s (1FG) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting FibroGen is a Buy.
FibroGen’s (1FG) 20-Day exponential moving average is 0.27, while FibroGen’s (1FG) share price is €0.26, making it a Buy.
FibroGen’s (1FG) 50-Day exponential moving average is 0.29, while FibroGen’s (1FG) share price is €0.26, making it a Sell.

FibroGen (1FG) Pivot Points

Jun 10, 2025, 12:01 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Fibonacci
0.26
0.26
0.26
0.26
0.26
0.26
0.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

FibroGen (1FG) Moving Averages

Jun 10, 2025, 12:01 AM
Period
Simple
Exponential
MA5
0.26Buy
0.27Buy
MA10
0.27Buy
0.27Buy
MA20
0.27Buy
0.27Buy
MA50
0.26Buy
0.29Sell
MA100
0.35Sell
0.33Sell
MA200
0.34Sell
0.38Sell
FibroGen’s (1FG) 10-Day exponential moving average is 0.27, while FibroGen’s (1FG) share price is €0.26, making it a Buy.
FibroGen’s (1FG) 100-Day exponential moving average is 0.33, while FibroGen’s (1FG) share price is €0.26, making it a Sell.
FibroGen’s (1FG) stock price is €0.26 and FibroGen’s (1FG) 50-day simple moving average is 0.26, creating a Buy signal.
FibroGen’s (1FG) stock price is €0.26 and FibroGen’s (1FG) 100-day simple moving average is 0.35, creating a Sell signal.
FibroGen’s (1FG) stock price is €0.26 and FibroGen’s (1FG) 200-day simple moving average is 0.34, creating a Sell signal.

FibroGen (1FG) Technical Indicators

Jun 10, 2025, 12:01 AM
Name
Value
Implied Action
RSI (14)
51.93
Neutral
STOCH (9,6)
35.46
Neutral
STOCHRSI (14)
35.46
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
9.96
Buy
Williams %R
-36.17
Buy
CCI (14)
12.56
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
54.35
Neutral
ROC
6.95
Buy
FibroGen’s (1FG) Relative Strength Index (RSI) is 51.93, creating a Neutral signal.
FibroGen’s (1FG) Trend Strength Indicator (ADX) is 9.96, creating a Buy signal.
FibroGen’s (1FG) Commodity Channel Index (CCI) is 12.56, creating a Neutral signal.
FibroGen’s (1FG) Price Rate of Change (ROC) is 6.95, creating a Buy signal.

FAQ

Is 1FG a Buy, Hold, or Sell?
Based on 1FG’s technical indicators, 1FG is a Buy.
    What is 1FG’s RSI (14)?
    1FG’s RSI (14) is 51.93, which suggests 1FG is a Neutral.
      What is 1FG’s MACD?
      1FG’s MACD is >-0.01, which suggests 1FG is a Buy.
        What is 1FG’s 5-day moving average?
        1FG’s 5-day moving average is 0.26, which suggests 1FG is a Buy.
          What is 1FG’s 20-day moving average?
          1FG 20-day moving average is 0.27, which suggests 1FG is a Buy.
            What is 1FG’s 50-day moving average?
            1FG’s 50-day moving average is 0.26, which suggests 1FG is a Buy.
              What is 1FG’s 200-day moving average?
              1FG’s 200-day moving average is 0.34, which suggests 1FG is a Sell.
                What is 1FG’s Williams % R (14)?
                1FG’s Williams % R (14) is -36.17, which suggests 1FG is a Buy.
                  What is 1FG’s CCI (14)?
                  1FG’s CCI (14) is 12.56, which suggests 1FG is a Neutral.
                    What is the share price of FibroGen?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis